Disclosure statement
Vinay Prasad reports royalties from Johns Hopkins Press, Medscape, MedPage, consulting for UnitedHealthcare, and speaking fees for Evicore. Vinay Prasad has a plenary session podcast that has Patreon backers. Vinay Prasad is funded to study low value drugs through a grant from Arnold Ventures. Aaron Goodman reports consulting for Seattle Genetics and EUSA Pharma. None of the authors have any other conflicts of interest.